Related references
Note: Only part of the references are listed.Effects of anticoagulants on the activity of gelatinases
Massimiliano Castellazzi et al.
CLINICAL BIOCHEMISTRY (2007)
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
V. Wee Yong et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Protein co-expression with axonal injury in multiple sclerosis plaques
M Diaz-Sanchez et al.
ACTA NEUROPATHOLOGICA (2006)
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis
E Fainardi et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Metalloproteinases: Mediators of pathology and regeneration in the CNS
VW Yong
NATURE REVIEWS NEUROSCIENCE (2005)
Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells
M Abraham et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Development of biomarkers in multiple sclerosis
B Bielekova et al.
BRAIN (2004)
MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity
J Esparza et al.
FASEB JOURNAL (2004)
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
A Bar-Or et al.
BRAIN (2003)
Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS
J Correale et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
C Avolio et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis
M Kouwenhoven et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
RLP Lindberg et al.
BRAIN (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica
RN Mandler et al.
BRAIN (2001)
Share Paper
